Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

122.09 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
47 48 Next >
Novartis Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bullish stance on Novartis. Looking at options history for Novartis (NYSE:NVS) we detected 21 strange trades. 
Via Benzinga
European Drug Makers Say Higher Energy Costs Eating Margins: Report
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs. 
Via Benzinga
Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?
Eli Lilly (LLY) shares rallied 4.9% in the last trading session to close at $310.87. This move can be attributable to notable volume with a higher number of shares being traded than in a typical... 
Via Talk Markets
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
Though successful in early testing, it wasn't enough to win a Phase 3 study. 
Via Investor's Business Daily
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
 
Via Benzinga
Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..
Reuters 
Via Benzinga
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
 
Via Benzinga
7 Safe Havens All Investors Should Have Exposure to in 2022
Few stocks with deep value and growth prospects offer upside and safe havens for investors, with those picks the exception. 
Via InvestorPlace
Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..
Wall Street Journal 
Via Benzinga
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
 
Via Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology. 
Via InvestorPlace
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition
 
Via Benzinga
Novartis Injects $300M In Early-Stage Biologics Research Tech
 
Via Benzinga
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
 
Via Benzinga
Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx
Continue reading "Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx" 
Via Get News
5 Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China's Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More..
US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike 
Via Benzinga
Swiss Competition Commission Investigates Novartis' Patent Use To Fend Off Competition
The Swiss competition commission (COMCO) has initiated an investigation against Novartis AG (NYSE: NVS) over the alleged unlawful patent use to reduce competitive pressure.  
Via Benzinga
VideoKrtoon Offers State Of The Art 2D Animation Services
Via Prodigy
Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims
A federal judge dismissed a whistleblower lawsuit accusing Novartis AG (NYSE: NVS) of paying doctors kickbacks at "sham" speaker programs to boost prescriptions of its multiple sclerosis blockbuster... 
Via Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati 
Via Benzinga
5 Value Stocks In The Healthcare Sector
What are Value Stocks? 
Via Benzinga
Smart Manufacturing Market Share 2022 Size, Key Trends, Future Scope, Global Outlook, Investment Plans and Development Status by 2027
Smart Manufacturing Market 2022 | Major Key Players included in this Report are Pfizer , Novartis, Abbott Laboratories and Many More with SWOT Analysis by 2027 
Via SBWire
No Early Relief for JW Therapeutics from Cancer Wonder Drug
Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down.  Large-scale market expansion is not going to be easy  The... 
Via Benzinga
Appointment of Sachin Nanavati to PreveCeutical's Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"... 
Via Newsfile
SiO2 Materials Science Names Yves Steffen as Chief Executive Officer
SiO2 Materials Science today announced the Board of Directors has appointed Yves Steffen as CEO effective Aug. 1, 2022. 
Via Newswire.com
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
Wall Street Journal 
Via Benzinga
Novartis Appoints Merck Executive As Research Head
 
Via Benzinga
NYSE:NVS Investor Alert: Investigation over Potential Wrongdoing at Novartis AG
San Diego, CA -- (SBWIRE) -- 08/30/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Novartis AG. 
Via SBWire
Novartis' Scemblix Snags European Approval For Chronic Myeloid Leukemia
 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.